Interpretation of the results of methacholine inhalation challenge tests

Russell J. Hopp, Sam J. Weiss, Nicki M. Nair, Againdra K. Bewtra, Robert G. Townley

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Methacholine inhalation challenge studies are conventionally expressed as the provocative cumulative dose of methacholine that causes a 20% fall in FEV1 (PD20). This method is widely used and most suitable for expressing results for challenges in subjects with asthma. However, it is impossible to present results in this manner in other circumstances. Normal subjects and many subjects with allergic rhinitis do not have significant bronchial reactivity and will not reach a 20% fall during standard challenge protocols. This limitation precludes the use of this large population in the quantitative analysis necessary in epidemiologic, genetic, or drug studies. To compound this difficulty, a subset of patients with allergic rhinitis may demonstrate a 20% drop but have a subsequent plateau drop in FEV1. Expressing the results of their methacholine challenge with only a PD20 loses valuable information available in the test. We demonstrate that expressing results as the area beneath a dose-response curve provides useful parametric data on all studied subjects and distinguishes among subjects who might otherwise be classified as equivalent when results are expressed solely as a PD20.

Original languageEnglish
Pages (from-to)821-830
Number of pages10
JournalJournal of Allergy and Clinical Immunology
Volume80
Issue number6
DOIs
StatePublished - 1987
Externally publishedYes

Fingerprint

Methacholine Chloride
Inhalation
Asthma
Pharmaceutical Preparations
Population
Allergic Rhinitis

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy

Cite this

Interpretation of the results of methacholine inhalation challenge tests. / Hopp, Russell J.; Weiss, Sam J.; Nair, Nicki M.; Bewtra, Againdra K.; Townley, Robert G.

In: Journal of Allergy and Clinical Immunology, Vol. 80, No. 6, 1987, p. 821-830.

Research output: Contribution to journalArticle

Hopp, Russell J. ; Weiss, Sam J. ; Nair, Nicki M. ; Bewtra, Againdra K. ; Townley, Robert G. / Interpretation of the results of methacholine inhalation challenge tests. In: Journal of Allergy and Clinical Immunology. 1987 ; Vol. 80, No. 6. pp. 821-830.
@article{e84f6e86e0fb4b7da03c7546b1c2e16a,
title = "Interpretation of the results of methacholine inhalation challenge tests",
abstract = "Methacholine inhalation challenge studies are conventionally expressed as the provocative cumulative dose of methacholine that causes a 20{\%} fall in FEV1 (PD20). This method is widely used and most suitable for expressing results for challenges in subjects with asthma. However, it is impossible to present results in this manner in other circumstances. Normal subjects and many subjects with allergic rhinitis do not have significant bronchial reactivity and will not reach a 20{\%} fall during standard challenge protocols. This limitation precludes the use of this large population in the quantitative analysis necessary in epidemiologic, genetic, or drug studies. To compound this difficulty, a subset of patients with allergic rhinitis may demonstrate a 20{\%} drop but have a subsequent plateau drop in FEV1. Expressing the results of their methacholine challenge with only a PD20 loses valuable information available in the test. We demonstrate that expressing results as the area beneath a dose-response curve provides useful parametric data on all studied subjects and distinguishes among subjects who might otherwise be classified as equivalent when results are expressed solely as a PD20.",
author = "Hopp, {Russell J.} and Weiss, {Sam J.} and Nair, {Nicki M.} and Bewtra, {Againdra K.} and Townley, {Robert G.}",
year = "1987",
doi = "10.1016/S0091-6749(87)80272-5",
language = "English",
volume = "80",
pages = "821--830",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Interpretation of the results of methacholine inhalation challenge tests

AU - Hopp, Russell J.

AU - Weiss, Sam J.

AU - Nair, Nicki M.

AU - Bewtra, Againdra K.

AU - Townley, Robert G.

PY - 1987

Y1 - 1987

N2 - Methacholine inhalation challenge studies are conventionally expressed as the provocative cumulative dose of methacholine that causes a 20% fall in FEV1 (PD20). This method is widely used and most suitable for expressing results for challenges in subjects with asthma. However, it is impossible to present results in this manner in other circumstances. Normal subjects and many subjects with allergic rhinitis do not have significant bronchial reactivity and will not reach a 20% fall during standard challenge protocols. This limitation precludes the use of this large population in the quantitative analysis necessary in epidemiologic, genetic, or drug studies. To compound this difficulty, a subset of patients with allergic rhinitis may demonstrate a 20% drop but have a subsequent plateau drop in FEV1. Expressing the results of their methacholine challenge with only a PD20 loses valuable information available in the test. We demonstrate that expressing results as the area beneath a dose-response curve provides useful parametric data on all studied subjects and distinguishes among subjects who might otherwise be classified as equivalent when results are expressed solely as a PD20.

AB - Methacholine inhalation challenge studies are conventionally expressed as the provocative cumulative dose of methacholine that causes a 20% fall in FEV1 (PD20). This method is widely used and most suitable for expressing results for challenges in subjects with asthma. However, it is impossible to present results in this manner in other circumstances. Normal subjects and many subjects with allergic rhinitis do not have significant bronchial reactivity and will not reach a 20% fall during standard challenge protocols. This limitation precludes the use of this large population in the quantitative analysis necessary in epidemiologic, genetic, or drug studies. To compound this difficulty, a subset of patients with allergic rhinitis may demonstrate a 20% drop but have a subsequent plateau drop in FEV1. Expressing the results of their methacholine challenge with only a PD20 loses valuable information available in the test. We demonstrate that expressing results as the area beneath a dose-response curve provides useful parametric data on all studied subjects and distinguishes among subjects who might otherwise be classified as equivalent when results are expressed solely as a PD20.

UR - http://www.scopus.com/inward/record.url?scp=0023597314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023597314&partnerID=8YFLogxK

U2 - 10.1016/S0091-6749(87)80272-5

DO - 10.1016/S0091-6749(87)80272-5

M3 - Article

VL - 80

SP - 821

EP - 830

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 6

ER -